R. E. Bridgewater, J. C. Norman, and P. T. Caswell, Integrin trafficking at a glance, Journal of Cell Science, vol.125, issue.16, pp.3695-3701, 2012.
DOI : 10.1242/jcs.095810

Y. Fang, Y. Jiang, Y. Zou, F. Meng, J. Zhang et al., Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles, Acta Biomater, 2017.
DOI : 10.1016/j.actbio.2017.01.007

B. Felding-habermann, B. M. Mueller, C. A. Romerdahl, and D. A. Cheresh, Involvement of integrin alpha V gene expression in human melanoma tumorigenicity., Journal of Clinical Investigation, vol.89, issue.6, pp.2018-2022, 1992.
DOI : 10.1172/JCI115811

M. Goutayer, S. Dufort, V. Josserand, A. Royere, E. Heinrich et al., Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.2, pp.137-147, 2010.
DOI : 10.1016/j.ejpb.2010.02.007

A. Jacquart, M. Keramidas, J. Vollaire, R. Boisgard, G. Pottier et al., LipImage 815: novel dye-loaded lipid nanoparticles for longterm and sensitive in vivo near-infrared fluorescence imaging, J Biomed Opt, vol.18, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01057402

A. Karageorgis, M. Claron, R. Juge, C. Aspord, F. Thoreau et al., Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model, Molecular Therapy, vol.25, issue.2, pp.534-546, 2017.
DOI : 10.1016/j.ymthe.2016.11.002

A. Karageorgis, S. Dufort, L. Sancey, M. Henry, S. Hirsjarvi et al., An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors, Scientific Reports, vol.33, issue.1, p.21417, 2016.
DOI : 10.1002/eji.200323712

URL : https://hal.archives-ouvertes.fr/hal-01388813

C. Mas-moruno, F. Rechenmacher, and H. Kessler, Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation, Anti-Cancer Agents in Medicinal Chemistry, vol.10, issue.10, pp.753-768, 2010.
DOI : 10.2174/187152010794728639

J. Merian, R. Boisgard, P. A. Bayle, M. Bardet, B. Tavitian et al., Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.93, pp.1-10, 2015.
DOI : 10.1016/j.ejpb.2015.03.019

L. Sancey, E. Garanger, S. Foillard, G. Schoehn, A. Hurbin et al., Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide, Mol Ther, vol.17, pp.837-843, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00369024

M. Sutherland, A. Gordon, S. D. Shnyder, L. H. Patterson, and H. M. Sheldrake, RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis, Cancers, vol.4, issue.4, pp.1106-1145, 2012.
DOI : 10.3390/cancers4041106

Y. Xu, J. Xu, W. Shan, M. Liu, Y. Cui et al., The transport mechanism of integrin ?? v ?? 3 receptor targeting nanoparticles in Caco-2 cells, International Journal of Pharmaceutics, vol.500, issue.1-2, pp.42-53, 2016.
DOI : 10.1016/j.ijpharm.2016.01.028

Y. Zhong, F. Meng, C. Deng, and Z. Zhong, Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy, Biomacromolecules, vol.15, issue.6, pp.1955-1969, 2014.
DOI : 10.1021/bm5003009

Y. Zhu, J. Zhang, F. Meng, C. Deng, R. Cheng et al., cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo, Journal of Controlled Release, vol.233, pp.29-38, 2016.
DOI : 10.1016/j.jconrel.2016.05.014